CVS Health Q1 2025 Financial Highlights

CVS Health Corporation announced a 7% annual increase in revenue for the first quarter of fiscal year 2025, reaching $94.6 billion, albeit below market expectations. The company reported a net income of $1.78 billion, a significant rise from $1.12 billion in the same period last year. Diluted earnings per share (EPS) also saw an uptick to $1.41, compared to $0.88 in Q1 2024.

Revised Full-Year Guidance

In light of the current financial landscape, CVS Health has adjusted its full-year 2025 cash flow from operations guidance downward by $500 million to $7.0 billion. Additionally, the GAAP diluted EPS guidance is now projected to range between $4.23 and $4.43.

Leadership's Perspective

"Our unwavering commitment to our customers has enabled CVS Health to achieve positive outcomes across all segments, including Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. We are dedicated to enhancing health outcomes for the 185 million consumers we serve," stated President and CEO David Joyner. Following the earnings report, CVS shares experienced a 4.79% increase in premarket trading, reaching $71.5 per share.